|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, January 18, 2018 )
A glucose tolerance test measures how well a body’s cells is capable to engross glucose, or sugar, after a patient consume a given amount of sugar. Doctors and specialists use fasting blood sugar levels and haemoglobin A1c values to identify type 1 and type 2 diabetes, and pre-diabetes whereas a glucose tolerance test can also be used. Doctors primarily use a glucose tolerance test to diagnose gestational diabetes in patients.
The Global Glucose Tolerance Test Market is expected to grow at a CAGR of 10.4% during the forecast period 2017-2023.
Specialists and doctors often diagnose type 1 diabetes swiftly because it frequently develops quickly and includes high blood sugar levels. Type 2 diabetes, on the other hand regularly develops over years. Type 2 diabetes is the most common form of diabetes, and it generally develops during adulthood. Gestational diabetes arises when a pregnant woman who do not have diabetes before pregnancy, thus has high blood sugar levels as a result of the pregnancy. The American Diabetes Association estimates that gestational diabetes occurs in 9.2 percent of pregnancies.
The Global Glucose Tolerance Test Market is expected to reach high growth figures in 2023, this market is expected to grow at a healthy CAGR of 10.4% during the forecast period 2017-2023. Factors such as Increasing prevalence and incidence of diabetes mellitus (DM), Rise in technological innovations, Research funding in diabetes diagnosis and treatment, and rising awareness and screening for Diabetes Mellitus are some of the major factors driving the growth of the market. Further Stringent reimbursement and insurance policies in developing nations, High cost associated with diagnosis and treatment of diabetes can hamper the market growth in coming future.
Glucose Tolerance Test Market Segmentation:
The Global Glucose Tolerance Test Market is segmented on the basis of products, indications, end user.
On the basis of the products, it is further segmented into intramedullary Blood glucose testing kit (Lancet, Meters, Test strips and others), Smart sensors and other .
On the basis of the indication, the market is segmented into Diabetes, Gestational diabetes, Insulin resistance, Reactive hypoglycemia.
On the basis of the end user, the market is segmented into Diagnostic Clinics, Hospitals, Home, and others.
Glucose Tolerance Test Market Key Findings:
On the basis of indications, Diabetes is the fastest growing market and is expected to reach USD 21,796.0 million by 2023 from USD 10,579.1million in 2016 at a CAGR of 10.7% during the forecast period of 2017-2023.
On the basis of products, Blood glucose testing kit is expected to reach USD 36,164.0million by 2023 from USD 17,676.0 million in 2016, at a CAGR of 10.6% during the forecast period of 2017-2023.
On the basis of End users, Diagnostic Clinics is expected to reach USD 15,335.9 million in 2023 for USD 7,999.9 million in 2016. Home segment is expected to be the fastest growing segment which is growing at a healthy CAGR of 10.9%
Glucose Tolerance Test Market Key Players:
Some of the key players in this market are Panasonic, Dexcom, Inc, Abbott Laboratories, F. Hoffman-La Roche Ltd, LifeScan, Inc Sanofi, Medtronic Plc and others
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4921 .
Regional Analysis
The Americas dominate the Diabetes Monitors Market owing to the presence of patient population, a well-developed technology, high healthcare expenditure, and the presence of the leading players. Due to high prevalence of the condition, companies, private organization, and government associations actively participates to improve diabetes care. For instance, The Merck Foundation provided funding of USD 10,000,000 for the projects designed to improve access to diabetes care and to reduce health disparities for vulnerable populations with type 2 diabetes in the United States.
Europe holds the second position in the diabetes monitors market. It is expected that the support provided by the government bodies for research & development, along with a well-developed technology drives the market in European region. According to the German maternity guidelines, every pregnant women can undergo glucose-challenge test for early diagnosis of Gestational diabetes mellitus (GDM). The charges for the test are completely covered by women’s health insurance.
TABLE OF CONTENTS
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Glucose Tolerance Test Market By Products
7 Global Glucose Tolerance Test Market By Indication
8 Global Glucose Tolerance Test Market By End Users
9 Global Glucose Tolerance Test Market By Regions
10 Competitive Landscape
11 Company Profile
12 Conclusion
… T.O.C. Continued
Get Discount @ https://www.marketresearchfuture.com/check-discount/4921 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Marketresearchfuture
Market Research Future
+1 (646) 845 9349
sales@wiseguyreports.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
